1672-8629
2013 Issue 6
Study on the Long Term Toxicity of Ganoderma Lucidum Granule to Rats
GAO Jian-bo;HAN Jing
GAO Jian-bo;HAN Jing
..............page:324-327,329
Discussion on the Relationship between National Essential Medicine System and Adverse Drug Reaction Monitoring
LIU Cui-li;HOU Yong-fang;SONG Qiu-jie;TIAN Chun-hua
LIU Cui-li;HOU Yong-fang;SONG Qiu-jie;TIAN Chun-hua
..............page:334-336
A Study of Drug Safety Monitoring Awareness Assessment Index System for Drug-producing Enterprises Staff Based on Delphi Method
GAO Jing;TIAN Ke-ren;YU Chao;ZHOU Juan;XU Jin;WAN Kai-hua;LI Sui
GAO Jing;TIAN Ke-ren;YU Chao;ZHOU Juan;XU Jin;WAN Kai-hua;LI Sui
..............page:344-347
Dialectically Viewing the Status of Adverse Drug Reaction Monitoring and Evaluation in China
LI Wen-wu
LI Wen-wu
..............page:337-340,343
The History and Expectation of Classification Management of Drugs in China
LIU Chun-guang;JIN Feng;YUAN Guo-hui
LIU Chun-guang;JIN Feng;YUAN Guo-hui
..............page:348-351,354
Hepatic Lesion Risk Analysis of Yangxueshengfa Capsule
LI Li-hua;CHEN Yong-fa
LI Li-hua;CHEN Yong-fa
..............page:362-365
Thoughts on National Medical Device Evaluation Information System Construction
LAN Weng-chi;XU Wei
LAN Weng-chi;XU Wei
..............page:341-343
The Therapeutic Method and Theoretical Evidence of Blood-activating and Stasis-removing Therapy of Intracerebral Hemorrhage
ZHANG Gen-ming;ZHOU Li;MA Bin;CUI Fang-yuan;CHEN Ying
ZHANG Gen-ming;ZHOU Li;MA Bin;CUI Fang-yuan;CHEN Ying
..............page:352-354
Analysis of Adverse Events and Related Factors of Implantable Cardiac Pacemaker
YU Wen-wem;ZHAO Yan;QING Shan
YU Wen-wem;ZHAO Yan;QING Shan
..............page:366-368,372
Pharmaceutical Care for a Patient with BRIC Type 2
QIN Li;WU Rong-rong;LIU Miao;LIU Feng-qun;CAO Ming-xue;HAN Jin
QIN Li;WU Rong-rong;LIU Miao;LIU Feng-qun;CAO Ming-xue;HAN Jin
..............page:375-377
yi si di fen zi you xuan tang zuo an ji suan zhu she ye you fa ji xing zuo xin shuai jie zhi si zhi 1 li
zhang zuo ; lin qiang ; lin xiao yan ; zuo yuan yuan
zhang zuo ; lin qiang ; lin xiao yan ; zuo yuan yuan
..............page:381-382
ben zha bei te zhi niao du zheng huan zhe yao wu xing ji yan 1 li
zhang zuo ; huang wei min ; tian ya fei
zhang zuo ; huang wei min ; tian ya fei
..............page:380-380
Research Development on the Protection of the Active Constituent of Ligusticum chuanxiong Hort against Ischemic Cerebrovascular Disease
CHI Xue-jie;SUN Rong
CHI Xue-jie;SUN Rong
..............page:355-357,361
Analysis of 94 Cases of Drug-induced Liver Injury
WANG Ji-mei;ZHANG Cui-fang;ZHAO Shou-mei
WANG Ji-mei;ZHANG Cui-fang;ZHAO Shou-mei
..............page:369-372
..............page:378-380
Application of Risk Matrix in Post-marketing Drug Risk Assessment: A Case Study of Terfenadine
YANG Le;GUO Xiao-xin;SONG Hai-bo
YANG Le;GUO Xiao-xin;SONG Hai-bo
..............page:358-361
Pharmaceutical Care for a Patient with Allergic Rhinitis and Cold by Clinical Pharmacists
YU Hui-bin;WANG Kui;XIONG Hui
YU Hui-bin;WANG Kui;XIONG Hui
..............page:373-374,377
..............page:328-329
Long-term Toxicity of Brucea Jananica Oil Injection in Rats
MA Hai-ping;DAI Xue-dong;DAI Xiao-li;MA Yu-kui
MA Hai-ping;DAI Xue-dong;DAI Xiao-li;MA Yu-kui
..............page:330-333
The Identified Study on Adverse Reactions of Ginkgolide Injection
LIU Yu-jie;XIAO Wei;WANG Zhen-zhong;ZHAO Bin-jiang;TIAN Heng-yong;HUANG Yu-hong;GUO Jia-kui;WENG Wei-liang
LIU Yu-jie;XIAO Wei;WANG Zhen-zhong;ZHAO Bin-jiang;TIAN Heng-yong;HUANG Yu-hong;GUO Jia-kui;WENG Wei-liang
..............page:321-323
e luo ti ni zhi ji suan ji mei sheng gao gan mei sheng gao shi yu jian tui 1 li
zheng ce ; zhen jian cun
zheng ce ; zhen jian cun
..............page:382-382
li xi bao ji luo ci ji yin zi you fa fei sun shang zhi si wang 2 li
zhao hong ; wan sui gui ; sun wan ling ; su li ; xia chang qing
zhao hong ; wan sui gui ; sun wan ling ; su li ; xia chang qing
..............page:383-384